Test a named article against its full compendial monograph.

Give ACTA the article and its monograph, and we run the entire required panel: identity, assay, related substances, water, and impurity tests the monograph names. Complete compendial testing applies whether the article is an incoming raw material or a finished drug product, using the applicable monograph and test panel for that article. FDA-registered, DEA-licensed, cGMP since 1990.

MONOGRAPH PANELcGMP
IdentificationIR <197>Conforms
AssayHPLC <621>Meets
Related substances<621>Meets
Loss on drying<731>Meets
Water (Karl Fischer)<921>Meets
Residue on ignition<281>Meets
Elemental impurities<232> / <233>Meets
Residual solvents<467>Meets
PHARMACOPEIA USP-NFDELIVERABLE cGMP COA
FDA Registered
DEA Licensed I to V
cGMP Compliant
Analyzing Since 1990
USP MONOGRAPH TESTING

What monograph testing covers

A USP monograph is the official specification for a named article. It lists every test the article has to pass, the method for each test, and the acceptance criterion. Complete monograph testing means ACTA runs that entire panel against the article, not a single test in isolation, and reports the article to its monograph on one Certificate of Analysis.

ACTA tests to the USP/NF monograph, and to the EP, BP, CP, or JP monograph where one applies, using the compendial procedure, a method you have already validated, or a method ACTA develops and validates in house. Send us the article and the monograph, and a chemist and/or microbiologist scopes the panel.

A typical monograph panel covers identity by infrared <197> and the general identification tests <191>; assay by HPLC or titration per <621>; related substances and organic impurities by HPLC; loss on drying <731> or water by Karl Fischer <921>; residue on ignition <281>; elemental impurities <232> and <233>; and residual solvents <467>, plus the article-specific tests the monograph names. The COA states each attribute, its result, the specification, and the pharmacopeia and edition applied.

Related USP Chapters
<191> Identification<197> IR Identification<621> Chromatography<731> Loss on Drying<281> Residue on Ignition<921> Water Determination<232> Elemental Impurities Limits<233> Elemental Impurities Procedures<467> Residual Solvents<1226> Verification of Compendial Procedures<1225> Validation of Compendial Procedures<1224> Transfer of Analytical Procedures
Pharmacopeia
USP / NFEPBPJP
ONE PANEL, TWO CONTEXTS

Separate monographs apply to the raw material and to the finished product for each active ingredient.

This is why monograph testing stands on its own. A compendial monograph can govern an incoming active, excipient, or the finished dosage form it becomes. ACTA runs the named panel in either context, so one lab can carry the article from the raw lot through the product it ships in.

As a raw material or API

Incoming actives, excipients, and raw materials

Confirm identity, assay, and purity of an incoming active or excipient against its monograph before it enters production. Identity by <197> and <191>, assay and related substances by <621>, water, and impurity tests the monograph names.

Raw material testing →
As a finished drug product

Manufactured lots of drug product

Run the product monograph on a manufactured lot to support lot disposition, including the finished-dose tests a monograph adds, such as dissolution <711>, uniformity of dosage units <905>, and disintegration <701>, alongside identity, assay, and related substances.

Finished product testing →
THE METHOD

Compendial or not, the method has to be proven when full cGMP compliance is needed

A monograph hands you the method, but the method still has to be shown to work in the lab that runs it for full cGMP compliance. ACTA offers USP <1226> Verification of Compendial Procedures to confirm that a compendial method performs for your specific article, on ACTA's instruments and analysts, to support full cGMP compliance. It is a targeted check of the attributes that matter, such as specificity, accuracy, precision, and a system suitability check, not a full revalidation.

When the monograph procedure is changed, or an alternative method is used in its place, that method needs full validation to USP <1225> and ICH Q2 and has to be shown equivalent to the compendial method. Methods moving between labs are handled by transfer under USP <1224>.

ACTA offers development, validation, verification, and transfer services in house. The same lab that runs your monograph can complete this cGMP requirement, if requested. See method development and validation.

FROM NAMED ARTICLE TO CERTIFICATE OF ANALYSISflow
NAMED ARTICLEThe named article and its monograph.ARTICLEmaterial or productFit the method to the article.METHOD FITverify or validateif cGMP requiredConfirm identity.IDENTITYIR <197>Run the monograph panel.MONOGRAPH PANELassay + purityReport against the monograph.COAper monograph

From the named article to the COA: fit the method, confirm identity, run the monograph panel, and report against the monograph. Hover any stage to see what it does.

1990Analyzing since
13,000 sq ftTwo buildings, Foothill Ranch CA
DEA Schedules I to VFDA-registered, DEA-licensed, cGMP
USP, BP, EP, JPCompendial methods
HOW WE RUN IT

Five steps, and a chemist runs each one.

ScopeA chemist and/or microbiologist reviews your article, its monograph, and which pharmacopeia and edition apply.
Verify and ValidatePerform Method Verification or Method Validation if requested for full cGMP compliance.
MethodFollow the compendial or non-compendial method.
AnalysisIdentity, assay, related substances, water, and impurity tests the monograph names, under cGMP.
ReportA cGMP Certificate of Analysis (COA) citing the monograph and pharmacopeia edition, and we follow up.
REGISTRATIONS & COMPLIANCE

Registrations, scope, and quality systems

FDA Establishment RegistrationRegistered · FEI No. 1000125694
DEA LicenseSchedules I to V · License No. RA0256239
Quality SystemcGMP, 21 CFR Parts 210, 211, and 820
Data Integrity21 CFR Part 11 Computer Systems coupled with Good Documentation Practices
CompendiaUSP, BP, JP, and EP methods
FDA Inspection History14 inspections (NDA, ANDA, and general cGMP) · Most recent Sept. 2026, 2 minor observations
Certificate of AnalysisConcise 1 to 2 page cGMP Certificate of Analysis (COA)
Established1990 · 13,000 sq ft, two buildings · Foothill Ranch, CA
ScopePharmaceutical and medical device, FDA-regulated only
Typical Quote Turnaround1 working day

Send us the article and its monograph.

A specific article against a specific monograph, raw material or finished product. We will scope the panel, get you a quote, and a chemist will follow up. FDA-registered, DEA-licensed, cGMP since 1990.
Request a Quote
949-595-0641
info@actalabs.com